Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1111-1120 Newer>

The Motley Fool April 13, 2004 Lita Epstein	GE Bets on Health Care Closing a $9.5 billion deal for the U.K.'s Amersham assures a major role for GE Healthcare.
The Motley Fool April 13, 2004 Alyce Lomax	J&J Makes the Day It may be over a hundred years old, but the company reports a spry first quarter.
Inc. April 1, 2004 Bobbie Gossage	Stella Ogiale - Chesterfield Health Services Ogiale founded Chesterfield Health Services in 1996 to give home care to mentally or physically disabled patients who would otherwise have to be institutionalized.
The Motley Fool April 12, 2004 Charly Travers	Bargain Hunting in Big Biotech MedImmune's recent FluMist troubles may have created a buying opportunity for long-term investors.
The Motley Fool April 12, 2004 Brian Gorman	Abbott Not Rewarded Abbott Laboratories first-quarter earnings news was positive, but investors didn't react enthusiastically.
The Motley Fool April 12, 2004 Brian Gorman	Forest Labs Faces Skeptics Its star drug Namenda, a new treatment for Alzheimer's disease, is taking heat from doctors.
BusinessWeek April 19, 2004 Joan O'C. Hamilton	Journey To The Center Of The Mind "Functional" MRI is yielding a clearer picture of what thoughts look like
BusinessWeek April 19, 2004 Gene G. Marcial	NPS: Ripe For A Buyout Little-known NPS Pharmaceuticals, which develops recombinant proteins to treat bone, gastrointestinal, and nervous disorders, is catching the eye of Big Pharma with its pipeline of products.
The Motley Fool April 8, 2004 Charly Travers	Indevus' Big Score (Maybe) A small biotech company lands a potentially rich deal.
The Motley Fool April 8, 2004 Brian Gorman	Genentech's Healthy Showing The company's first-quarter results were impressive, driven by pricey cancer drugs.
<Older 1111-1120 Newer> Return to current articles.